Fortis Healthcare Limited
All news and filings related to Fortis Healthcare Limited.
View all news & filings- Medium impact
Fortis Healthcare Faces Forensic Audit Over Past Transactions
Fortis Healthcare's Investors/Analysts' meet transcript reveals a Delhi High Court order for a forensic audit of past transactions, including IHH's acquisition. The audit has a 6-month timeline. Fortis and IHH remain confident, stating the order doesn't impact strategic plans or future investments. Legal expenses were ~₹25 crore last year.
Read the summary - Low impact
Fortis Healthcare Revises Schedule for Investor Meet with IHH Healthcare in London
Fortis Healthcare Limited and IHH Healthcare Berhad will hold an investor and analyst meet on September 14-15, 2026, in London. The non-deal roadshow, organized by Jefferies, will discuss business updates and industry trends. No price-sensitive information will be shared.
Read the summary - Low impact
Fortis Healthcare Announces Revised Investor Meet Schedule in London
Fortis Healthcare Limited and IHH Healthcare Berhad will hold investor and analyst meetings in London on September 14-15, 2026. The in-person group meet, organized by Jefferies, will cover business updates and industry discussions. No UPSI will be shared.
Read the summary - Low impact
Fortis Healthcare Schedules Investor Meet in London on Sep 14-15
Fortis Healthcare Limited will hold an investor and analyst meet in London on September 14-15, 2026. Organized by Jefferies, the event will cover general business updates and industry discussions. Meetings are scheduled from 8 AM to 5 PM BST (12:30 PM to 9:30 PM IST). No UPSI will be shared.
Read the summary - Low impact
Fortis Healthcare to hold Investor/Analyst Meet in London on Sep 14-15
Fortis Healthcare Limited will conduct an investor and analyst meet in London on September 14-15, 2026. Organized by Jefferies, the meetings will involve one-on-one and group sessions to discuss general business updates and the industry. No Unpublished Price Sensitive Information will be shared.
Read the summary - Low impact
Fortis Healthcare: Audio recording of Investor/Analyst Meet available online.
Fortis Healthcare released the audio recording of its Investor/Analyst Meet held on September 4, 2026. The meeting focused on discussing recent company developments. The recording is accessible on the company's website.
Read the summary - Low impact
Fortis Healthcare and IHH Healthcare to hold Investor Call on Sep 4, 2026
Fortis Healthcare Limited and IHH Healthcare Berhad will jointly host a virtual conference call on September 4, 2026, at 1:00 PM IST. The management will provide updates on recent developments. Dial-in details for international and Indian participants are available, with a replay option provided.
Read the summary - Medium impact
Fortis Healthcare: Delhi HC orders forensic audit on erstwhile promoter shareholding
The Delhi High Court ordered a forensic audit into the dissipation of erstwhile promoters' shareholding in Fortis Healthcare. The audit will investigate changes in control and stakeholder roles. No liability has been imposed on the company, which was not a party to the original dispute.
Read the summary - Medium impact
Fortis Healthcare Receives Strong ESG Rating of 'Crisil ESG 66' and 'Crisil Core ESG 72'
Fortis Healthcare Limited received strong ESG ratings of 'Crisil ESG 66' and 'Crisil Core ESG 72' for FY2025-26 from Crisil ESG Ratings & Analytics Ltd. The ratings were voluntarily assigned by Crisil based on publicly available data.
Read the summary - Medium impact
Fortis Healthcare Q1 FY27: Revenue up 17.5% to ₹2,545 Cr, PAT at ₹263 Cr
Fortis Healthcare reported Q1 FY27 consolidated revenue of ₹2,545 Cr, up 17.5%. PAT was ₹263 Cr. Hospital revenue grew 19% to ₹2,187 Cr, and diagnostics revenue rose 10.2% to ₹407 Cr. The company is investing in new facilities and technology, including a proton therapy unit. A broad-based ESOP scheme was approved for doctors and senior staff.
Read the summary - Medium impact
Fortis Healthcare Concludes 30th AGM; Declares Final Dividend of ₹1 Per Share
Fortis Healthcare's 30th AGM was held on August 11, 2026. The company declared a final dividend of ₹1 per equity share for FY26. Key resolutions included re-appointments of directors and the MD & CEO. Voting results are expected by August 13, 2026.
Read the summary - Medium impact
Fortis Healthcare Publishes Q1 FY27 Un-Audited Financial Results
Fortis Healthcare Limited published its un-audited financial results for Q1 FY27. Consolidated total income was ₹2,55,950 Lakhs, with a net profit after tax of ₹27,280 Lakhs. Standalone total income was ₹50,837 Lakhs, with a net profit after tax of ₹4,778 Lakhs. The results were published on August 7, 2026.
Read the summary - Low impact
Fortis Healthcare: Audio Recording of Q1FY27 Investor Meet Available Online
Fortis Healthcare has made the audio recording of its investor and analyst meet available online. The meet, held on August 7, 2026, discussed the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.
Read the summary - High impact
Fortis Healthcare Q1FY27 Consolidated Revenue at ₹2,545 Crore, Up 17.5%
Fortis Healthcare reported Q1FY27 consolidated revenue of ₹2,545 crore, up 17.5% YoY. Operating EBITDA increased by 15.8% to ₹568 crore. Hospital business revenue grew 19% to ₹2,187 crore, and diagnostics business revenue rose 10.2% to ₹407 crore. Net debt was ₹2,233 crore.
Read the summary - High impact
Fortis Healthcare Q1 FY27: Revenue up 17.5% to ₹2,545 Cr; Hospital Revenue grows 19%
Fortis Healthcare reported Q1 FY27 consolidated revenues of ₹2,545 Cr, up 17.5% YoY. Hospital revenue rose 19% to ₹2,187 Cr. The company entered an O&M agreement for a 300-bed hospital in Cuttack, Odisha, and plans to add ~1,800 beds in 4-5 years.
Read the summary - Medium impact
Fortis Healthcare Q1 FY27 Results: Net Profit Rises to ₹477.8 Crore, Appoints B S R & Co. LLP as Tax Auditors
Fortis Healthcare reported a net profit of ₹477.8 crore for the quarter ended June 30, 2026. Total income was ₹50,837 lacs. The company also appointed B S R & Co. LLP as its Tax Auditors for FY 2025-26.
Read the summary - Medium impact
Fortis Healthcare Q1 FY27 Results: Net Profit Declines to ₹477.8 Crore
Fortis Healthcare reported Q1 FY27 results with total income at ₹5,083.7 crore. Net profit declined to ₹477.8 crore from ₹518.8 crore year-on-year. Diluted EPS was ₹0.63. The company also appointed B S R & Co. LLP as Tax Auditors for FY26.
Read the summary - Medium impact
Fortis Healthcare subsidiary Agilus Diagnostics to merge two wholly-owned subsidiaries
Agilus Diagnostics Limited, a subsidiary of Fortis Healthcare, will merge Agilus Pathlabs Private Limited and DDRC Agilus Pathlabs Limited into itself. The merger, approved on August 5, 2026, is an intra-group restructuring and requires NCLT approval. No consideration will be paid.
Read the summary - Low impact
Fortis Healthcare Schedules Q1FY27 Post-Results Conference Call for August 7, 2026
Fortis Healthcare Limited will host a virtual conference call on August 7, 2026, at 11:00 am IST to discuss its unaudited Q1FY27 financial results. Dial-in details and a participation link have been provided. No UPSI will be shared.
Read the summary - Low impact
Fortis Healthcare Invites for Q1FY27 Results Conference Call on Aug 07
Fortis Healthcare Limited will host a conference call on August 7, 2026, at 11:00 AM IST to discuss its unaudited Q1FY27 financial results. Dial-in details and a virtual participation link are available. No UPSI will be shared.
Read the summary - Medium impact
Fortis Healthcare: Final Dividend of ₹1 Per Share Recommended; AGM on Aug 11
Fortis Healthcare recommended a final dividend of ₹1 per equity share for FY26. The 30th AGM is scheduled for August 11, 2026, to approve the dividend. The record date is July 24, 2026. Shareholders must update details and submit TDS-related declarations by August 5, 2026.
Read the summary - Medium impact
Agilus Diagnostics Appoints Vijender Singh as MD & CEO
Agilus Diagnostics, a Fortis Healthcare subsidiary, appointed Vijender Singh as MD & CEO. Singh brings over 30 years of experience in diagnostics and healthcare leadership. He succeeds Dr. Anand K. The appointment aims to strengthen market position and drive growth.
Read the summary - Low impact
Fortis Healthcare Announces 30th AGM on August 11, 2026, with E-voting Facility
Fortis Healthcare will hold its 30th AGM on August 11, 2026, via Video Conference. Remote e-voting is open from August 6-10, 2026. The cut-off date for voting eligibility is August 4, 2026. The Annual Report for FY 2025-26 has been dispatched.
Read the summary - Low impact
Fortis Healthcare Fixes July 24 Record Date for ₹1 Dividend Payment
Fortis Healthcare has set July 24, 2026, as the record date for its final dividend of ₹1 per equity share for FY 2025-26. The dividend is subject to shareholder approval at the AGM on August 11, 2026. The Register of Members will be closed from July 25 to August 11, 2026.
Read the summary - Low impact
Fortis Healthcare Fixes July 24, 2026 as Record Date for ₹1 Final Dividend
Fortis Healthcare has set July 24, 2026, as the record date for its final dividend of ₹1 per equity share for FY 2025-26. The dividend is subject to approval at the AGM on August 11, 2026. The company's share transfer books will close from July 25 to August 11, 2026.
Read the summary - Low impact
Fortis Healthcare schedules 30th AGM for August 11, 2026, to discuss FY26 Annual Report
Fortis Healthcare Limited will hold its 30th AGM on August 11, 2026, at 12:00 PM IST via VC/OAVM. The meeting will cover the Annual Report for FY 2025-26. Shareholders can access reports online. Unregistered email holders receive physical letters with weblinks.
Read the summary - Low impact
Fortis Healthcare Announces 30th AGM on Aug 11, 2026; Releases Annual Report FY26
Fortis Healthcare will hold its 30th AGM on August 11, 2026. The company released its Annual Report for FY 2025-26, detailing ESG progress. Its ESG rating improved to 68 from 58, with significant gains in environmental metrics. Key initiatives include energy efficiency and water recycling.
Read the summary - Medium impact
Fortis Healthcare to hold 30th AGM on Aug 11, 2026; proposes ₹1 dividend
Fortis Healthcare will hold its 30th AGM on August 11, 2026, via VC/OAVM. The company proposes a final dividend of ₹1 per equity share for FY 2025-26. Key agenda items include director appointments, auditor remuneration, and approval for independent director commission up to ₹77.17 lakhs annually. Dr. Ashutosh Raghuvanshi's re-appointment as MD & CEO for two years from March 19, 2027, with remuneration up to ₹11.23 crore, is also proposed.
Read the summary - Low impact
Fortis Healthcare Announces 30th AGM on August 11, 2026
Fortis Healthcare will hold its 30th AGM on August 11, 2026, via video conference. The financial year 2025-26 annual report will be shared via email by July 3, 2026. August 4, 2026, is the cut-off for e-voting eligibility. Dividend payment is scheduled by September 9, 2026.
Read the summary - Medium impact
Fortis Healthcare Recommends Re-appointment of Dr. Ashutosh Raghuvanshi as MD & CEO for 2 Years
Fortis Healthcare's Board recommended re-appointing Dr. Ashutosh Raghuvanshi as MD & CEO for two years, effective March 19, 2027. This is subject to shareholder approval. Dr. Raghuvanshi has over 38 years of experience in healthcare.
Read the summary - Medium impact
Fortis Healthcare Board Recommends Dr. Ashutosh Raghuvanshi's Re-appointment as MD & CEO for 2 Years
Fortis Healthcare's Board recommended re-appointing Dr. Ashutosh Raghuvanshi as MD & CEO for two years, effective March 19, 2027. This is subject to shareholder approval. Dr. Raghuvanshi has over 38 years of experience in healthcare.
Read the summary - Medium impact
Fortis Healthcare Signs O&M Agreement for 300-Bed Multi-Specialty Hospital in Cuttack, Odisha
Fortis Healthcare signed an O&M agreement with Dion Group for a 300-bed multi-specialty hospital in Cuttack, Odisha. This marks Fortis's entry into Odisha, expanding its network and improving access to advanced tertiary care in Eastern India.
Read the summary - Low impact
Fortis Healthcare: Northern TK Venture Discloses Shareholding as of March 31, 2026
Northern TK Venture Pte. Ltd. disclosed holding 235,295,895 equity shares in Fortis Healthcare Limited as of March 31, 2026. The company confirmed no share encumbrance during the financial year ended March 31, 2026, as per SEBI Takeover Regulations.
Read the summary - Medium impact
Fortis Healthcare Subsidiary's Tax Demand Reduced by ₹55.56 Crore
Fortis Healthcare's subsidiary, Fortis Hospitals Limited, had its tax demand for AY 2024-25 reduced from ₹117.04 Crore to ₹61.48 Crore. This reduction of ₹55.56 Crore was achieved through a successful rectification application processed by the Income Tax Authority.
Read the summary - High impact
Fortis Healthcare FY26 Revenue at ₹9,128 Crore, Up 17.3%; Recommends ₹1 Dividend
Fortis Healthcare reported FY26 consolidated revenue of ₹9,128 crore, up 17.3%. The company recommended a ₹1 per share dividend. Hospital business revenue grew 19.1% to ₹7,773 crore, and diagnostics revenue was ₹1,355 crore. Consolidated profit after tax surged 31.5% to ₹1,064 crore. Management expects 15% revenue growth in FY27 for hospitals.
Read the summary - Low impact
Fortis Healthcare: Audio Recording of Q4FY26 Investor Meet Available Online
Fortis Healthcare Limited has made the audio recording of its investor and analyst meet available online. The meet, held on May 25, 2026, discussed the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026.
Read the summary - Medium impact
Fortis Healthcare Publishes Audited Financial Results for FY26
Fortis Healthcare published its audited financial results for Q4 FY26 and FY26 on May 23, 2026. Standalone Q4 revenue was ₹2369.06 crore with ₹27.95 crore net profit. Consolidated Q4 revenue was ₹413.46 crore with ₹20.12 crore net profit. FY26 standalone revenue was ₹2273 crore, net profit ₹153.02 crore.
Read the summary - Medium impact
Fortis Healthcare Approves FY26 Audited Results & Recommends ₹1 Dividend
Fortis Healthcare's Board approved audited standalone and consolidated financial results for FY26 ending March 31, 2026, with an unmodified auditor opinion. A final dividend of ₹1 per share was recommended, pending member approval. M/s Jitender, Navneet & Co. appointed as Cost Auditor for FY27.
Read the summary - Medium impact
Fortis Healthcare Recommends ₹1 Final Dividend; Approves FY26 Audited Results
Fortis Healthcare approved its audited financial results for FY26, reporting total income of ₹917,850 lacs and net profit of ₹106,419 lacs. The board recommended a final dividend of ₹1 per equity share and appointed M/s Jitender, Navneet & Co. as Cost Auditors for FY27.
Read the summary - Medium impact
Fortis Healthcare Board Approves Audited FY26 Results, Recommends ₹1 Dividend
Fortis Healthcare's Board approved audited FY26 results. The company reported consolidated revenue of ₹912,784 lacs for the year ended March 31, 2026. A final dividend of ₹1 per equity share was recommended, subject to member approval. M/s Jitender, Navneet & Co. appointed as Cost Auditor for FY26-27.
Read the summary - Medium impact
Fortis Healthcare Approves FY26 Audited Results and Recommends ₹1 Dividend
Fortis Healthcare announced audited standalone and consolidated financial results for the year ended March 31, 2026. The company recommended a final dividend of ₹1 per equity share for FY26. M/s Jitender, Navneet & Co. were appointed as Cost Auditors for FY27. The Board Meeting concluded on May 22, 2026.
Read the summary - High impact
Fortis Healthcare Q4 FY26 Revenue Up 17.8% to ₹2,365 Cr; PAT Rises 44.2% to ₹271 Cr
Fortis Healthcare reported Q4 FY26 consolidated revenue of ₹2,365 Cr, up 17.8% YoY. PAT increased 44.2% to ₹271 Cr. For FY26, revenue was ₹9,128 Cr (up 17.3%) and PAT was ₹1,064 Cr (up 31.5%). The Board recommended a dividend of ₹1 per share.
Read the summary - High impact
Fortis Healthcare Q4 FY26 Revenue up 17.8% to ₹2,365 Cr, PAT surges 44.2% to ₹271 Cr; Recommends Dividend
Fortis Healthcare reported Q4 FY26 consolidated revenue of ₹2,365 Cr, up 17.8% YoY. PAT surged 44.2% to ₹271 Cr. For FY26, revenue grew 17.3% to ₹9,128 Cr, and PAT rose 31.5% to ₹1,064 Cr. The board recommended a dividend of ₹1 per share. The company also completed acquisitions and expanded its network.
Read the summary - Medium impact
Fortis Healthcare Approves FY26 Audited Results and Recommends ₹1 Dividend
Fortis Healthcare's Board approved FY26 audited standalone and consolidated results. A final dividend of ₹1 per equity share is recommended. M/s Jitender, Navneet & Co. appointed as Cost Auditor for FY27. The Board meeting was held on May 22, 2026.
Read the summary - Medium impact
Fortis Healthcare Recommends ₹1 Final Dividend, Approves FY26 Audited Results
Fortis Healthcare's Board approved FY26 audited results and recommended a ₹1 per share final dividend for FY25-26. The company also appointed a new Cost Auditor for FY26-27 and approved its CSR policy.
Read the summary - Medium impact
Fortis Healthcare Board Approves FY26 Audited Results and Recommends ₹1 Dividend
Fortis Healthcare's Board approved FY26 audited results and recommended a ₹1 per share final dividend. M/s Jitender, Navneet & Co. appointed as Cost Auditor for FY27. The company reported consolidated annual income of ₹917,850 lacs and net profit attributable to owners of ₹106,419 lacs.
Read the summary - Low impact
Fortis Healthcare Schedules Q4FY26 Results Conference Call for May 25
Fortis Healthcare Limited will host a conference call on May 25, 2026, at 11:00 AM IST to discuss its Q4FY26 and full-year FY26 audited financial results. Dial-in details for participants are available, and a replay will be offered.
Read the summary - Medium impact
Fortis Healthcare: NTK's Litigation Against Daiichi Sankyo Judgment Scheduled for Sept 10, 2026
Fortis Healthcare announced an update on litigation filed by promoter shareholder NTK against Daiichi Sankyo. The Tokyo District Court has concluded proceedings, with the judgment announcement scheduled for September 10, 2026. This pertains to the transaction involving IHH Healthcare's acquisition of shares in Fortis.
Read the summary - Low impact
Fortis Healthcare Grants Over 1.32 Crore Stock Options Under ESOP 2026
Fortis Healthcare granted 1,32,05,200 stock options under ESOP 2026 on April 23, 2026. Each option is exercisable into one equity share of ₹10 face value. The exercise price is ₹923.10. Vesting occurs within 3 years, and exercise within 4 years of vesting.
Read the summary - Low impact
Fortis Healthcare to hold Investor Meetings on April 27-28, 2026
Fortis Healthcare Limited will conduct investor and analyst meetings on April 27-28, 2026. The non-deal roadshow, organized by JM Financial, will include in-person one-on-one and group meetings in Mumbai to discuss general business and industry updates.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio